Appointment booking for Dr. Neal Moskowitz, MD is currently not available.Dr. Neal Moskowitz, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Neal Moskowitz, MD (he/him) is a Rheumatologist in Philadelphia, PA with over 17 years of experience. What is your opinion of Dr. Neal Moskowitz, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 17 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Neal Moskowitz, MD has received over $10,827 which includes payments from the following companies:
$1,541.56 from Genentech USA, Inc.
$1,258.92 from Amgen Inc.
$1,207.47 from AbbVie, Inc.
$1,124.34 from Pfizer Inc.
$898.77 from UCB, Inc.
$678.26 from Janssen Biotech, Inc.
$554.65 from Celgene Corporation
$540.41 from Novartis Pharmaceuticals Corporation
$428.09 from Mallinckrodt LLC
$399.22 from GlaxoSmithKline, LLC.
$326.91 from LILLY USA, LLC
$280.76 from E.R. Squibb & Sons, L.L.C.
$243.88 from GENZYME CORPORATION
$164.47 from MEDAC PHARMA, INC.
$122.16 from Antares Pharma, Inc.
$110.62 from West-Ward Pharmaceuticals
$106.97 from Sobi, Inc
$90.93 from Questcor Pharmaceuticals
$77.95 from sanofi-aventis U.S. LLC
$69.36 from Takeda Pharmaceuticals America, Inc.
Payments received by Dr. Neal Moskowitz, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!